Drugs / AV-006
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03931876 Comparator | Jun → Sep 2019 | bacterial infectious disease | Arixa Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AV-006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03931876 ↗ |
| Route | Oral | “to be administered orally” NCT03931876 ↗ |